{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:45:15Z","timestamp":1792449915305,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijid.2020.09.016","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:43:07Z","timestamp":1599738187000},"page":"327-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":286,"special_numbering":"C","title":["Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-4244","authenticated-orcid":false,"given":"Lawrence B.","family":"Afrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.09.016_bib0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2020.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5315\/wjh.v3.i1","article-title":"A concise, practical guide to diagnostic assessment for mast cell activation disease","volume":"3","author":"Afrin","year":"2014","journal-title":"World J Hematol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2015.07.002","article-title":"Mast cell activation disease: an underappreciated cause of neurologic and psychiatric symptoms and diseases","volume":"50","author":"Afrin","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.ijid.2020.09.016_bib0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/07853890.2016.1161231","article-title":"Often seen, rarely recognized: mast cell activation disease\u2013a guide to diagnosis and therapeutic options","volume":"48","author":"Afrin","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.ijid.2020.09.016_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2016.01.003","article-title":"Mast cell activation disease and the modern epidemic of chronic inflammatory disease","volume":"174","author":"Afrin","year":"2016","journal-title":"Transl Res"},{"issue":"22","key":"10.1016\/j.ijid.2020.09.016_bib0030","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood.V128.22.4878.4878","article-title":"Mast cell regulatory gene variants are common in mast cell activation syndrome","volume":"128","author":"Afrin","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijid.2020.09.016_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjms.2016.12.013","article-title":"Characterization of mast cell activation syndrome","volume":"353","author":"Afrin","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijid.2020.09.016_bib0040","article-title":"Diagnosis of mast cell activation syndrome: a global \u201cconsensus-2\u201d","author":"Afrin","year":"2020","journal-title":"Diagnosis (Berl)"},{"issue":"1","key":"10.1016\/j.ijid.2020.09.016_bib0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics","volume":"114","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0050","doi-asserted-by":"crossref","first-page":"109883","DOI":"10.1016\/j.mehy.2020.109883","article-title":"The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for Montelukast","volume":"143","author":"Almerie","year":"2020","journal-title":"Med Hypotheses"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.016_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00251-017-0981-y","article-title":"Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing","volume":"69","author":"Altm\u00fcller","year":"2017","journal-title":"Immunogenetics"},{"issue":"21","key":"10.1016\/j.ijid.2020.09.016_bib0060","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically Ill patients in the Seattle region\u2013case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"issue":"SI-1","key":"10.1016\/j.ijid.2020.09.016_bib0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3906\/sag-2004-172","article-title":"Epidemiology of COVID-19","volume":"50","author":"Bulut","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ijid.2020.09.016_bib0070","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2020.09.016_bib0075","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14068","article-title":"What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?","author":"Criado","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ijid.2020.09.016_bib0085","first-page":"1","article-title":"Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy","author":"Fominskiy","year":"2020","journal-title":"Blood Purif"},{"issue":"16","key":"10.1016\/j.ijid.2020.09.016_bib0090","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2020.09.016_bib0095","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.053","article-title":"Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study","author":"Freedberg","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijid.2020.09.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2020.09.016_bib0105","doi-asserted-by":"crossref","first-page":"109856","DOI":"10.1016\/j.mehy.2020.109856","article-title":"Sodium chromo-glycate and palmitoylethanolamide: a possible strategy to treat mast cell-induced lung inflammation in COVID-19","volume":"143","author":"Gigante","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijid.2020.09.016_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2020.06.013","article-title":"The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19","author":"Goker Bagca","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ijid.2020.09.016_bib0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cca.2020.06.033","article-title":"Hyperferritinemia in critically ill COVID-19 patients\u2013is ferritin the product of inflammation or a pathogenic mediator?","volume":"509","author":"G\u00f3mez-Pastora","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.ijid.2020.09.016_bib0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"Haenisch","year":"2012","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.ijid.2020.09.016_bib0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00251-014-0768-3","article-title":"Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease","volume":"66","author":"Haenisch","year":"2014","journal-title":"Immunogenetics"},{"issue":"20","key":"10.1016\/j.ijid.2020.09.016_bib0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2217\/fon-2020-0300","article-title":"Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?","volume":"16","author":"Hays","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0135","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3390\/ijms20143395","article-title":"Mast cells in cardiovascular disease: from bench to bedside","volume":"20","author":"Hermans","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2020.09.016_bib0140","series-title":"\u201cMast Cells\u201d in COPE: Cytokines and Cells Online Pathfinder Encyclopaedia","author":"Ibelgaufts","year":"2020"},{"key":"10.1016\/j.ijid.2020.09.016_bib0145","doi-asserted-by":"crossref","DOI":"10.1177\/1073858420941476","article-title":"COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ijid.2020.09.016_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21673\/anadoluklin.720116","article-title":"Mast cell stabilizers as a supportive therapy can contribute to alleviate fatal inflammatory responses and severity of pulmonary complications in COVID-19 infection","author":"K\u0131l\u0131nc","year":"2020","journal-title":"Anadolu Klini\u011fi T\u0131p Bilimleri Dergisi"},{"issue":"1","key":"10.1016\/j.ijid.2020.09.016_bib0155","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","volume":"34","author":"Kritas","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.ijid.2020.09.016_bib0160","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fimmu.2015.00620","article-title":"The mast cell: a multi-functional mast cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2020.09.016_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12079-020-00569-0","article-title":"COVID-19: is fibrosis the killer?","volume":"14","author":"Leask","year":"2020","journal-title":"J Cell Commun Signal"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.016_bib0170","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/jcm9061917","article-title":"COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection","volume":"9","author":"Lechowicz","year":"2020","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ijid.2020.09.016_bib0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ijid.2020.09.016_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"issue":"10229","key":"10.1016\/j.ijid.2020.09.016_bib0185","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.09.016_bib0190","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020006075","article-title":"JAK\/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation","author":"Meyer","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijid.2020.09.016_bib0195","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"11-12","key":"10.1016\/j.ijid.2020.09.016_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"issue":"9","key":"10.1016\/j.ijid.2020.09.016_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2020.09.016_bib0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","article-title":"The genetic basis of mast cell activation disease\u2013looking through a glass darkly","volume":"93","author":"Molderings","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.trsl.2016.01.001","article-title":"Transgenerational transmission of systemic mast cell activation disease-genetic and epigenetic features","volume":"174","author":"Molderings","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.ijid.2020.09.016_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ijid.2020.09.016_bib0225","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04377789Onal H. Effect of Quercetin on Prophylaxis and Treatment of COVID-19. 2020. Available at: [Accessed 2 August 2020]."},{"key":"10.1016\/j.ijid.2020.09.016_bib0230","first-page":"100768","article-title":"Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases [published online ahead of print, 2020 May 27]","volume":"78","author":"Rabec","year":"2020","journal-title":"Respir Med Res"},{"issue":"1","key":"10.1016\/j.ijid.2020.09.016_bib0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.1000273","article-title":"Mast cell stabilization improves survival by preventing apoptosis in sepsis","volume":"185","author":"Ramos","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0240","article-title":"Dexamethasone in hospitalized patients with Covid-19-preliminary report","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijid.2020.09.016_bib0245","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009937","article-title":"Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry","author":"Romero-S\u00e1nchez","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ijid.2020.09.016_bib0250","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2020.09.016_bib0255","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2020.01130","article-title":"Severe COVID-19, another piece in the Puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm","volume":"11","author":"Ruscitti","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0260","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3389\/fimmu.2020.01201","article-title":"Fighting the host reaction SARS-CoV-2 in critically ill patients: the possible contribution of off-label drugs","volume":"11","author":"Scala","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.016_bib0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000508247","article-title":"JAK inhibition as a new treatment strategy for patients with COVID-19","volume":"181","author":"Seif","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0270","first-page":"1","article-title":"In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme","author":"Sepay","year":"2020","journal-title":"Struct Chem"},{"key":"10.1016\/j.ijid.2020.09.016_bib0275","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fphar.2020.00854","article-title":"Repositioning chromones for early anti-inflammatory treatment of COVID-19","volume":"11","author":"Sestili","year":"2020","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.ijid.2020.09.016_bib0280","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0285","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04365985Sims M. Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (SINK COVID-19). 2020. Available at [Accessed 2 August 2020]."},{"key":"10.1016\/j.ijid.2020.09.016_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"47","key":"10.1016\/j.ijid.2020.09.016_bib0295","doi-asserted-by":"crossref","first-page":"eabc5367","DOI":"10.1126\/sciimmunol.abc5367","article-title":"HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19","volume":"5","author":"Spinelli","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0300","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1073\/pnas.1105079108","article-title":"Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance","volume":"108","author":"St John","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2020.09.016_bib0305","first-page":"S1359","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.ijid.2020.09.016_bib0310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/biof.1633","article-title":"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin","volume":"46","author":"Theoharides","year":"2020","journal-title":"Biofactors"},{"key":"10.1016\/j.ijid.2020.09.016_bib0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ijid.2020.09.016_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.06.009","article-title":"Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: expert opinions","author":"Valent","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2020.09.016_bib0325","doi-asserted-by":"crossref","first-page":"104950","DOI":"10.1016\/j.phrs.2020.104950","article-title":"Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study","volume":"158","author":"Viecca","year":"2020","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.016_bib0330","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"issue":"10229","key":"10.1016\/j.ijid.2020.09.016_bib0335","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.016_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220307323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220307323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T17:57:02Z","timestamp":1738432622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220307323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":68,"alternative-id":["S1201971220307323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.016","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}